Literature DB >> 17587837

Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation.

Sook Jung Yun1, Seong-Jin Kim.   

Abstract

BACKGROUND: Anagen effluvium is a common side effect of chemotherapy, but few studies have examined its clinical characteristics.
OBJECTIVE: This study was aimed at evaluating the hair loss caused by chemotherapeutic agents.
METHODS: Sixty-four patients with anagen effluvium were evaluated in the study. Chemotherapeutic agents were classified into 5 different groups. The pattern of hair loss was analyzed when specific involvement of the hairline was obvious.
RESULTS: Forty-six (71.9%) of the 64 total patients maintained hairs along their hairline. Hairs were maintained with a total hairline in 20 (31.3%), frontal hairline in 13 (20.3%) and occipital hairline in 12 (18.8%) patients. Among the 20 males with patterned hair loss, the following hairlines were preserved: occipital in 10 (50%), total in 7 (35%) and frontal in 3 (15%). Among the 25 females with patterned hair loss, hairlines were preserved as total in 13 (52%), frontal in 10 (40%) and occipital in 2 (8%). However, no significant differences were detected in hair loss patterns according to age, associated symptoms, chemotherapeutic agent group or combination of chemotherapeutic agents.
CONCLUSION: Our results suggest that anagen effluvium induced by chemotherapeutic agents represents patterned hair loss. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2007        PMID: 17587837     DOI: 10.1159/000102031

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  8 in total

1.  Testing chemotherapeutic agents in the feather follicle identifies a selective blockade of cell proliferation and a key role for sonic hedgehog signaling in chemotherapy-induced tissue damage.

Authors:  Guojiang Xie; Hangwei Wang; Zhipeng Yan; Linyan Cai; Guixuan Zhou; Wanzhong He; Ralf Paus; Zhicao Yue
Journal:  J Invest Dermatol       Date:  2014-09-18       Impact factor: 8.551

Review 2.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

3.  Dermatological Findings in Turkish Paediatric Haematology-Oncology Patients.

Authors:  Umit Uksal; Pinar Ozturk; Emine Colgecen; Nazan Taslidere; Turkan Patiroglu; Mehmet Akif Ozdemir; Yasemin Altuner Torun; Murat Borlu
Journal:  Eurasian J Med       Date:  2016-06

Review 4.  Psychological Aspects of Hair Disorders: Consideration for Dermatologists, Cosmetologists, Aesthetic, and Plastic Surgeons.

Authors:  Cameron R Moattari; Mohammad Jafferany
Journal:  Skin Appendage Disord       Date:  2021-11-23

5.  Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question.

Authors:  Alfredo Rebora; Marcella Guarrera
Journal:  Skin Appendage Disord       Date:  2021-05-06

6.  Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy.

Authors:  Kamuran Turker; Betul Tas; Murat Ozkaya; Ebru Tas; Aysel Caglar; Umit Seza Tetikkurt
Journal:  Hepat Mon       Date:  2015-03-20       Impact factor: 0.660

7.  A Descriptive Study to Analyze Chemotherapy-Induced Hair Loss and its Psychosocial Impact in Adults: Our Experience from a Tertiary Care Hospital.

Authors:  Neerja Saraswat; Ajay Chopra; Aradhana Sood; Parul Kamboj; Sushil Kumar
Journal:  Indian Dermatol Online J       Date:  2019 Jul-Aug

8.  Clinical and histological study of permanent alopecia after bone marrow transplantation.

Authors:  Flávia Machado Alves Basilio; Fabiane Mulinari Brenner; Betina Werner; Graziela Junges Crescente Rastelli
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.